Vasodilatory and Vibratory Treatment Improves Glymphatic Drainage in Humans
The glymphatic system provides pathways for cerebrospinal fluid to drain from the brain into the body, carrying with it metabolic waste from the brain. This waste material includes the protein aggregates associated with various neurodegenerative conditions, such as amyloid-β. The glymphatic system is primarily active during sleep, and relies upon (a) blood vessel pulsation to drive fluid flow in the perivascular spaces that run parallel to blood vessels, (b) water channels such as AQP-4 in astrocytes to permit fluid to enter perivascular spaces, and (c) the lymphatic vessels of the neck. Further, a portion of the glymphatic system runs through the cribriform plate bone behind the nose, and that relies upon channels in the plate remaining open. All of these points of reliance are negatively impacted by age, degrading fluid flow from the brain, and allowing metabolic waste to build up. This appears to be a meaningful contribution to the onset and development of neurodegenerative conditions.
Researchers have conducted proof of principle studies in animals and people for a range of possible approaches to improving glymphatic drainage of cerebrospinal fluid in aged individuals. Drugs that restore blood and lymphatic vessel smooth muscle function to help with pulsation-driven fluid fluid flow. Delivery of intermittent CO2 during sleep. Various gene therapies and small molecule drugs to improve AQP-4 function in astrocytes. And so forth. In today's open access paper, researchers provide evidence from a small human trial for a combination of vasodilatory therapy (using the very old approach of nitroglycerine to increase vasodilatory nitric oxide signaling) and vibration during sleep to improve glymphatic function. The addition of vibration is an interesting choice, given that there is animal study evidence for vasodilation alone to improve glymphatic drainage.
Vasomechanic treatment is associated with increased efflux of human brain proteins
The efficient removal of soluble metabolites and proteins from interstitial and cerebrospinal fluids (I/CSF) is essential for maintaining brain homeostasis. Impairment of brain clearance pathways has been linked to the earliest stages of neurodegenerative disease, preceding neuronal loss by years or decades. Experimental and clinical studies demonstrate that impaired clearance of soluble amyloid-β (Aβ) and phosphorylated tau protein from the CSF leads to their accumulation within perivascular and interstitial compartments, promoting their aggregation and accelerating neuropathology.
Recent findings suggest that CSF efflux can be modulated through physiological mechanisms that are both therapeutically targetable and monitorable in humans. Acute systemic vasodilation caused by hypotensive drugs such as nicardipine and sodium nitroprusside (SNP) has emerged as a potent enhancer of CSF solute efflux in rodents. Nitric oxide (NO) donors such as SNP increase movement of intracisternal tracers from the cranial cavity to the blood, predominantly via cervical lymph nodes, an effect that is accompanied by improved downstream lymphatic function. Local NO delivery to neck lymphatic plexuses similarly enhances efflux of intracranial tracers, demonstrating that modulation of vascular tone can directly augment CSF transport along g/lymphatic pathways
Mechanical stimulation of Piezo1, a mechanosensitive cation channel expressed ubiquitously in all tissues including vascular and lymphatic endothelia, presents a complementary route for modulating neurofluid flow. Recent work shows that even light mechanical stimulation activates Piezo1, increases endothelial NO synthase (eNOS) activity, and restores age-related deficits in cervical lymphatic efflux. Piezo1 activation also increases meningeal lymphatic drainage and improves learning and memory in mice.
In this study (EudraCT 2021-000625-27), we investigated the effects of sublingual NO and Piezo1-targeted whole-body vibrations (WBVp) in healthy adults (n = 29) using multimodal neuroimaging and blood biomarker analysis. The combined intervention (NO+WBVp) was associated with correlating changes in brain fluid dynamics and increased blood levels of soluble brain-derived proteins (Aβ40 and Aβ42, GFAP). These effects increased with age and the magnitude of NO-induced hypotension. The interventions were well tolerated under controlled experimental conditions. Overall, the findings are consistent with transient redistribution of brain-derived proteins toward circulation, suggesting a potential non-invasive approach to increase neurofluidic solute efflux in humans.